Using Imagery to Maintain Muscle Mass Gains in the Quadriceps — Maintaining Muscle Mass Gains
Citation(s)
Clark BC, Mahato NK, Nakazawa M, Law TD, Thomas JS The power of the mind: the cortex as a critical determinant of muscle strength/weakness. J Neurophysiol. 2014 Dec 15;112(12):3219-26. doi: 10.1152/jn.00386.2014.
Cumming, J , & Ramsey, R. (2009). Imagery interventions in sport. In S.D Mellalieu & S. Hanton (Eds.)., Advances in applied sport psychology: A review (pp.5-36). London: Routledge
Godin G, Shephard RJ A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6.
Holmes, P S., & Collins, D. J. (2001). The PETTLEP approach to motor imagery: A functional equivalence model for sport psychologists. Journal of Applied Sport Psychology, 13, 60-83.
Lebon F, Collet C, Guillot A Benefits of motor imagery training on muscle strength. J Strength Cond Res. 2010 Jun;24(6):1680-7. doi: 10.1519/JSC.0b013e3181d8e936.
Yao WX, Ranganathan VK, Allexandre D, Siemionow V, Yue GH Kinesthetic imagery training of forceful muscle contractions increases brain signal and muscle strength. Front Hum Neurosci. 2013 Sep 26;7:561. doi: 10.3389/fnhum.2013.00561.
Yao, G H., Wilson, S. L., Cole, K.J., Darline, W.G., Tuh, W. T. C. (1996). Imagined muscle contraction training increases voluntary neural drive to muscle. Journal of Pscyhophysiology, 10, 198-208.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
